Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,486.00    -10.00 (-0.40%)
Bid:
2,508.00
Ask:
2,510.00
Spread: 2.00 (0.08%)
Market Cap: £25.06b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Transaction in Own Shares

8 Jun 2026 07:00

RNS Number : 2839H
3i Group PLC
08 June 2026
 

8 June 2026

3i GROUP PLC

 

TRANSACTIONS IN OWN SHARES

 

 

 

3i Group plc (the "Company" or "3i") announces today that it has purchased for cancellation the following number of its ordinary shares of 73 19/22p each ("Shares") through Barclays Capital Securities Limited as part of the £750 million share buyback programme announced by 3i on 14 May 2026 (the "Programme"):

 

Date of transactions

Trading Venues

Aggregated volume (Shares)

Lowest Price per Share (£)

Highest Price per Share (£)

Volume weighted average price paid per share (£)

01/06/2026

London Stock Exchange

382,142

21.8800

22.8700

22.3890

02/06/2026

London Stock Exchange

443,399

21.3300

22.1100

21.6695

03/06/2026

London Stock Exchange

443,563

21.0600

21.6800

21.3753

04/06/2026

London Stock Exchange

444,642

21.4500

22.0900

21.9290

05/06/2026

London Stock Exchange

444,642

22.0100

22.4500

22.2224

 

 

Following the above purchase and cancellation of the Shares, the total number of voting rights in the 3i will be 1,018,927,288 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 3i does not hold any shares in treasury.

 

Since the commencement of this Programme, 3i has purchased 5,782,242 Shares for cancellation at an aggregate cost of £127,538,363.08 (excluding fees and taxes).

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the Programme is detailed below.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

http://www.rns-pdf.londonstockexchange.com/rns/2839H_1-2026-6-5.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGGVLKMGVZM
Date   Source Headline
30th Jun 20263:38 pmRNSTotal Voting Rights
30th Jun 20263:34 pmRNSAdmission to Trading
30th Jun 202612:00 pmRNSDirector/PDMR Shareholding
29th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20263:31 pmRNSDirectorate change
25th Jun 20263:28 pmRNSDoc re. AGM Resolutions
25th Jun 20263:23 pmRNSResult of AGM
25th Jun 20267:00 amRNSAGM and portfolio update
22nd Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202611:21 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20264:24 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:37 pmRNSDirector/PDMR Shareholding - Amendment
1st Jun 20264:28 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:38 pmRNSAdmission to Trading
27th May 202610:42 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:29 pmRNSDirector/PDMR Shareholding
21st May 20267:40 amRNSDoc re. 2026 Annual Report and Accounts
19th May 20262:28 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:24 amRNSDirector/PDMR Shareholding
14th May 202610:41 amRNSHolding(s) in Company
14th May 20267:02 amRNSCommencement of Share Buyback Programme
14th May 20267:00 amRNSResults for the year to 31 March 2026
1st May 202612:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSTotal Voting Rights
30th Apr 20263:31 pmRNSAdmission to Trading
7th Apr 202612:33 pmRNSHolding(s) in Company
1st Apr 20269:53 amRNSPortfolio Update
1st Apr 20269:36 amRNSDirector/PDMR Shareholding
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 20262:29 pmRNSAdmission to Trading
31st Mar 202611:37 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:07 pmRNSAdmission to Trading
26th Mar 20267:00 amRNSAction Capital Markets Seminar & portfolio update
23rd Mar 202612:11 pmRNSHolding(s) in Company
2nd Mar 202612:18 pmRNSDirector/PDMR Shareholding
27th Feb 20264:00 pmRNSTotal Voting Rights
3rd Feb 202610:20 amRNSHolding(s) in Company
3rd Feb 202610:17 amRNSDirector Declaration
30th Jan 20262:24 pmRNSDirector/PDMR Shareholding
30th Jan 20261:47 pmRNSTotal Voting Rights
29th Jan 202612:19 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSFY2026 Q3 performance update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.